Di Li

Di Li has extensive work experience in the biostatistics field. They currently hold the position of Vice President, Biostatistics and Programming at Jounce Therapeutics, Inc., a role they have held since March 2022. Prior to this, Di Li worked at Incyte as a Senior Director Biostatistics from September 2020 to March 2022. They also served as Director, Global Biometric Sciences, Oncology at Bristol-Myers Squibb from February 2018 to September 2020.

Before joining Bristol-Myers Squibb, Di Li held positions at Eisai. They were the Director, Biostatistics from July 2015 to February 2018 and the Associate Director, Biostatistics from January 2013 to July 2015. Prior to their time at Eisai, Di Li worked as a Senior Biostatistics Manager at Astellas Pharma from June 2011 to January 2013. They also gained experience at Abbott Laboratories, where they worked as a Research Statistician / Research Statistician II from August 2007 to June 2011.

Di Li received a Bachelor of Science degree in Atmospheric Physics from Peking University. Following this, they pursued a Master of Arts degree in Atmospheric and Oceanic Sciences at Princeton University from 2000 to 2002. Later, from 2003 to 2007, Di Li studied at the University of Illinois Urbana-Champaign, where they obtained a Doctor of Philosophy degree in Statistics.